NPC
CRDF icon

National Planning Corporation’s Cardiff Oncology CRDF Stock Holding History

National Planning Corporation’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-146
Closed -$59K – 629
2015
Q2 		$59K Hold
146
– – 0.01% 633
2015
Q1 		$89K Buy
146
+77
+112% +$32.8K 0.01% 626
2014
Q4 		$27.7K Buy
+69
New +$22.3K ﹤0.01% 1558

Other funds holding CRDF

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MWVC
Morgens Waterfall Vintiadis & Co New York $81.2M AUM 86.87% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

National Planning Corporation's CRDF Position: Q3 2015 in Review

National Planning Corporation sold out of Cardiff Oncology (CRDF) in Q3 2015, closing a stake of 146 shares — an estimated $59K sold.

National Planning Corporation first reported a position in CRDF in Q4 2014 and held it in 3 quarters. The position peaked at $89K in Q1 2015. 60 funds tracked by Wall St. Rank hold CRDF as of Q3 2015.

  • National Planning Corporation reported no remaining Cardiff Oncology position as of Q3 2015 after selling out during the quarter.
  • National Planning Corporation sold 146 Cardiff Oncology shares in Q3 2015, an estimated $59K.
  • National Planning Corporation first reported a position in Cardiff Oncology in Q4 2014 and held it in 3 quarters.
  • National Planning Corporation's Cardiff Oncology position peaked at $89K in Q1 2015.
  • 60 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2015.

Based on National Planning Corporation's 13F filing for Q3 2015, filed 12 Nov 2015.